In trading on Monday, shares of 10x Genomics Inc (Symbol: TXG) entered into oversold territory, hitting an RSI reading of 27.9, after changing hands as low as $11.8955 per share. By comparison ...
In this article, we are going to take a look at where 10x Genomics, Inc. (NASDAQ:TXG) stands against the other stocks in Cathie Wood's portfolio. Cathie Wood is one of Wall Street's most ...
In this article, we are going to take a look at where 10x Genomics, Inc. (NASDAQ:TXG) stands against the other stocks in Cathie Wood’s portfolio. Cathie Wood is one of Wall Street’s most ...
The market expects 10x Genomics (TXG) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus ...
NASDAQ TXG opened at $15.08 on Friday. The company has a market capitalization of $1.83 billion, a P/E ratio of -9.86 and a beta of 1.83. 10x Genomics has a 52-week low of $12.95 and a 52-week ...
2024 marks the sixth consecutive year production guidance has been achieved Toronto, Ontario--(Newsfile Corp. - January 8, 2025) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) ...
View 10x Genomics, Inc. (TXG) current and estimated P/E ratio data provided by Seeking Alpha.
Aquí puede consultar la cuenta de resultados de 10X Genomics (TXG), mostrando el estado financiero de la compañía, los ingresos, las actividades operativas y no operativas tales como beneficios ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results